Cash flow from operating activities CFO
-0.056 B
Last period CFO ,SEK
-96%
CFO has decreased in 5 years
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
See also Egetis Therapeutics
Company Analysis
EGTX.ST valuation, rating, competitors, insights and company profile
Eyestock Rating
EGTX.ST financial analysis by Eyestock methodology
Valuation
EGTX.ST valuation using historical relative method
Financials
EGTX.ST revenue, earnings, ROE, ROIC and other financials
Statements
EGTX.ST Income Statements, Balance Sheet and Cash Flow Statements
Dividends
EGTX.ST dividend yield and annual dividend
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
What is CFO of Egetis Therapeutics ?
Egetis Therapeutics`s CFO for the period ended 2024-06-30 is -0.056 B SEK